Monroe Bank & Trust’s Medtronic MDT Stock Holding History

Monroe Bank & Trust’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-100	Closed	-$8K	–	258
2017 Q4	$8K	Buy	+100	New	+$8.01K	﹤0.01%	248

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Monroe Bank & Trust's MDT Position: Q1 2018 in Review

Monroe Bank & Trust sold out of Medtronic (MDT) in Q1 2018, closing a stake of 100 shares — an estimated $8K sold.

Monroe Bank & Trust first reported a position in MDT in Q4 2017 and held it in 1 quarter. The position peaked at $8K in Q4 2017. 1,381 funds tracked by Wall St. Rank hold MDT as of Q1 2018.

Monroe Bank & Trust reported no remaining Medtronic position as of Q1 2018 after selling out during the quarter.
Monroe Bank & Trust sold 100 Medtronic shares in Q1 2018, an estimated $8K.
Monroe Bank & Trust first reported a position in Medtronic in Q4 2017 and held it in 1 quarter.
Monroe Bank & Trust's Medtronic position peaked at $8K in Q4 2017.
1,381 funds tracked by Wall St. Rank held Medtronic as of Q1 2018.

Based on Monroe Bank & Trust's 13F filing for Q1 2018, filed 14 May 2018.